True North Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,791
| Closed | -$509K | – | 204 |
|
|
2023
Q3 | $509K | Sell |
6,791
-6,654
| -49% | -$499K | 0.16% | 110 |
|
|
2023
Q2 | $1.04M | Sell |
13,445
-6,667
| -33% | -$514K | 0.29% | 65 |
|
|
2023
Q1 | $1.67M | Sell |
20,112
-1,975
| -9% | -$164K | 0.49% | 49 |
|
|
2022
Q4 | $1.9M | Buy |
22,087
+1,975
| +10% | +$170K | 0.65% | 40 |
|
|
2022
Q3 | $1.24M | Hold |
20,112
| – | – | 0.41% | 62 |
|
|
2022
Q2 | $1.24M | Sell |
20,112
-90
| -0.4% | -$5.56K | 0.39% | 67 |
|
|
2022
Q1 | $1.2M | Sell |
20,202
-39,944
| -66% | -$2.37M | 0.32% | 73 |
|
|
2021
Q4 | $4.37M | Buy |
60,146
+7,604
| +14% | +$552K | 0.74% | 27 |
|
|
2021
Q3 | $3.67M | Buy |
52,542
+25
| +0% | +$1.75K | 0.72% | 30 |
|
|
2021
Q2 | $3.62M | Hold |
52,517
| – | – | 0.75% | 26 |
|
|
2021
Q1 | $3.39M | Hold |
52,517
| – | – | 0.81% | 24 |
|
|
2020
Q4 | $3.06M | Sell |
52,517
-3,013
| -5% | -$176K | 0.79% | 32 |
|
|
2020
Q3 | $3.51M | Sell |
55,530
-79,985
| -59% | -$5.05M | 1.02% | 23 |
|
|
2020
Q2 | $10.4M | Buy |
135,515
+4,443
| +3% | +$342K | 2.51% | 11 |
|
|
2020
Q1 | $9.8M | Buy |
131,072
+27
| +0% | +$2.02K | 3.34% | 9 |
|
|
2019
Q4 | $8.52M | Buy |
+131,045
| New | +$8.52M | 2.4% | 12 |
|